ALLMedicine™ Pneumonia Center
Research & Reviews 23,614 results
https://doi.org/10.1016/j.ijid.2022.05.024
International Journal of Infectious Diseases : IJID : Off... Bozzi G, Saltini P et. al.
May 15th, 2022 - Pneumocystis jirovecii pneumonia (PCP) still has substantial morbidity and mortality. For non-HIV patients, course of infection is severe, and management guidelines relatively recent. We collected all PCP cases (EORTC criteria) diagnosed in HIV-ne...
https://doi.org/10.3390/ijerph19095419
International Journal of Environmental Research and Publi... Hsiao SY, Yao CT et. al.
May 15th, 2022 - Home care patients have swallowing dysfunction and rely on an in-dwelling nasogastric tube (NGT) to complement oral food intake, supplement their diet, and maintain adequate nutritional status. This study explored the relationship between aspirati...
https://doi.org/10.1016/j.anl.2022.04.011
Auris, Nasus, Larynx; Ohara K, Katada A et. al.
May 15th, 2022 - A 15-year-old girl presented with a 3-year-history of continuous outflow of saliva from a pharyngocutaneous fistula, located at 5 mm superior to her tracheal stoma. She was diagnosed with Miller-Dieker syndrome at birth. At 2 years of age, pediatr...
https://doi.org/10.1016/j.ijid.2022.05.002
International Journal of Infectious Diseases : IJID : Off... Malézieux-Picard A, Nascè A et. al.
May 14th, 2022 - Long term mortality is increased in elderly patients with pneumonia. We aimed to test if residual inflammation is predictive of one-year mortality after pneumonia. Inflammation biomarkers (CRP, Interleukin (IL)-6 and -8, TNFα, Serum Amyloid A, Neo...
https://doi.org/10.1007/s00464-022-09309-4 10.1016/S1470-2045(11)70142-5 10.1245/s10434-011-2049-9 10.1016/j.surg.2007.12.007 10.1097/00000658-199409000-00012 10.1097/00000658-199511000-00008 10.1056/NEJM199812313392704 10.1016/j.canlet.2008.10.020 10.1378/chest.127.6.1904 10.3748/wjg.v12.i16.2505 10.1097/SLA.0b013e3181bdd5a8 10.1016/S0140-6736(12)60516-9 10.1007/s00464-016-5081-9 10.4065/78.6.758 10.1007/s00464-014-3919-6 10.1007/s00464-016-5124-2 10.1007/s00423-019-01772-3 10.1097/SLA.0b013e3181b13ca2 10.1053/j.gastro.2015.04.053 10.1016/j.gtc.2009.01.004 10.1093/jjco/hyv178 10.1002/bjs.4022 10.1016/j.jamcollsurg.2006.03.016 10.1093/dote/dox047 10.1097/SLA.0000000000000644 10.1245/s10434-019-07627-x 10.1007/s00464-020-07455-1 10.1007/s10388-018-0617-9
Surgical Endoscopy; Goto H, Oshikiri T et. al.
May 14th, 2022 - Many patients with esophageal squamous cell carcinoma (ESCC) have obstructive ventilatory disorder (OVD), which is considered a risk factor for postoperative pneumonia. It has been reported that thoracoscopic esophagectomy in the prone position (T...
Guidelines 44 results
https://pubmed.ncbi.nlm.nih.gov/34839344/
Asian-Pacific Journal of Ophthalmology; Lin TPH, Ko CN et. al.
Nov 24th, 2021 - The coronavirus disease 2019 (COVID-19) came under the attention of the international medical community when China first notified the World Health Organization of a pneumonia outbreak of then-unknown etiology in Wuhan in December 2019. Since then,...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.
Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116237
Annals of Hematology; Classen AY, Henze L et. al.
Apr 14th, 2021 - Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new resear...
https://doi.org/10.1016/j.parkreldis.2021.03.027
Parkinsonism & Related Disorders; Calandra-Buonaura G, Alfonsi E et. al.
Apr 12th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by a combination of autonomic failure plus cerebellar syndrome and/or parkinsonism. Dysphagia is a frequent and disabling symptom in MSA and its occurrence within 5 years ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.
Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...
Drugs 1,280 results see all →
Clinicaltrials.gov 1,147 results
https://clinicaltrials.gov/ct2/show/NCT03908632
May 13th, 2022 - This is an observational study in 1,000 individuals aged 14 years or older, diagnosed with Community Acquired Pneumonia (CAP) who meet all eligibility criteria in Coccidioides endemic regions. This study is designed to provide data on the prevalen...
https://clinicaltrials.gov/ct2/show/NCT00077909
May 13th, 2022 - OBJECTIVE: The objective of this study is to analyze bronchoalveolar lavage (BAL) fluid from patients with lung infiltrates in order to discover new biomarkers and protein/peptide expression patterns that are associated with specific types of pulm...
https://clinicaltrials.gov/ct2/show/NCT05372731
May 13th, 2022 - ARDS caused by pneumonia is one of the main reasons for ICU admission in critically ill patients, and also a common complication in patients admitted to ICU with invasive mechanical ventilation. Bronchoalveolar lavage (BAL) is the main diagnostic ...
https://clinicaltrials.gov/ct2/show/NCT04924660
May 12th, 2022 - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. The clinical spectrum of COVID-19 infection is broad, encompassing asymptomatic infection, mild ...
https://clinicaltrials.gov/ct2/show/NCT02332577
May 12th, 2022 - The total study duration for each patient is 1 month with a treatment period of 7 to 9 days and a follow-up period of 21 to 23 days.
News 3,464 results
https://www.onclive.com/view/nab-paclitaxel-plus-pembrolizumab-produces-promising-responses-in-advanced-urothelial-cancer
May 2nd, 2022 - The combination of nab-paclitaxel (Abraxane) and pembrolizumab (Keytruda) produced an encouraging overall response rate (ORR) with manageable safety in patients with advanced urothelial cancer who were refractory to platinum-based chemotherapy or ...
https://www.medscape.com/viewarticle/972791
Apr 27th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Gross total resection is an independent predictor of longer survival and good postoperative functional recovery in...
https://www.medpagetoday.com/criticalcare/infectioncontrol/98411
Apr 26th, 2022 - In a small series from Ireland, patients in the intensive care unit (ICU) for severe COVID-19 were more likely to develop serious bacterial and fungal infections when they received the IL-6 inhibitor tocilizumab (Actemra), potentially reflecting t...
https://www.medscape.com/viewarticle/972666
Apr 25th, 2022 - COVID-19 was the third-leading cause of death in the United States in 2021 for the second straight year, with only heart disease and cancer causing more deaths, the CDC said Friday. About 693,000 people died of heart disease in 2021, with 605,000 ...
https://www.onclive.com/view/european-approval-sought-for-ivosidenib-in-idh1-mutated-aml-and-cholangiocarcinoma
Apr 22nd, 2022 - A marketing authorization application (MAA) has been submitted to the European Medicines Agency (EMA) for 2 indications of ivosidenib (Tibsovo): in combination with azacitidine in the frontline treatment of patients with IDH1-mutated acute myeloid...